Schering-Plough - Wikipedia
网页Schering-Plough Corporation was an American pharmaceutical company. It was originally the U.S. subsidiary of the German company Schering AG, which was founded in 1851 by Ernst Christian Friedrich Schering. As a result of nationalization, it …
Merck | Home
网页At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Merck, Schering-Plough set to complete merger | Reuters
网页NEW YORK (Reuters) - Merck & Co and Schering-Plough Corp said their $41.1 billion merger will be completed later on Tuesday, marking the close of the second huge deal in the pharmaceutical ...
Merck buys Schering-Plough for $41bn - Financial Times
网页2009年3月10日 · Merck on Monday announced an agreed $41bn takeover of its New Jersey rival, Schering-Plough, just six weeks after Pfizer’s $68bn takeover of Wyeth was unveiled.
Merck Announces Organon & Co. as New Company Name for …
网页2020年3月11日 · Organon has been an important part of Merck since the 2009 Schering-Plough acquisition. The Organon name has strong brand equity and engenders great respect among health care professionals for its dedication and innovation in women’s health.
Merck Looks To Recent Schering-Plough Merger For New Drug
网页2010年2月10日 · Regardless of whom the board selects to replace Clark, his legacy will rest on the merger with Schering-Plough and its efficacy in delivering blockbuster drugs to market.
Merck and Schering-Plough in $41B merger - CNN Business
网页2009年3月9日 · Pharmaceutical giants Merck & Co. and Schering-Plough Corp. announced Monday that they will merge in a deal worth more than $41 billion.
History - MSD
网页MSD and Schering-Plough completed a merger and began combined operations. The purchase made the company the second largest pharmaceutical company in United States by revenue.
Merck to Buy Schering-Plough for $41 Billion - The New York Times
网页2009年3月10日 · That was many analysts’ assessment Monday of Merck’s agreement to pay $41.1 billion in cash and stock for Schering-Plough. The merger would join pharmaceutical companies that had combined ...
Who we are - Merck.com
网页We aspire to be the premier research-intensive biopharmaceutical company. We’re at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals.